Addressing the need for more equitable cardio-oncology care requires attention to
existing disparities in cardio-oncologic disease prevention and outcomes. This is
particularly important among those affected by adverse social determinants of ...
Although recent advancements in cancer therapies have extended the lifespan of patients
with cancer, they have also introduced new challenges, including chronic health issues
such as cardiovascular disease arising from pre-existing risk factors ...
Cardiovascular and cancer outcomes intersect within the realm of cardio-oncology survivorship
care, marked by disparities across ethnic, racial, social, and geographical landscapes.
Although the clinical community is increasingly aware of this ...
• Situating engagement within the experience and priorities of survivors will enhance
translational research and health equity. • The TRUST framework provides a guide to expand opportunities for community engagement
in cardio-oncology ...
• Intersectionality of health inequities in CVD and cancer may compound inequities in
cardio-oncology. • Equitable access to clinical trials is 1 of many key strategies to mitigate these
health disparities. • Cardio-oncology trials ...
Background Cardiovascular disease (CVD) is a significant cause of morbidity and mortality in
men with prostate cancer; however, data on racial disparities in CVD outcomes are
limited. Objectives We quantified the disparities in CVD according ...
Background Maintaining cardiovascular health (CVH) is critical for breast cancer (BC) survivors,
particularly given the potential cardiotoxic effects of cancer treatments. Poor CVH
among Black BC survivors may be influenced by various area-...
Background Modifiable cardiovascular risk factors constitute a significant cause of cardiovascular
disease and mortality among patients with cancer. Recent studies suggest a potential
link between neighborhood walkability and favorable ...
Background Relationships between the social determinants of health (SDOH) and cardiovascular
health (CVH) of cancer survivors are underexplored. Objectives This study sought to investigate associations between the SDOH and CVH of adult cancer
...
Background Transthyretin amyloid cardiomyopathy (ATTR-CM) is associated with significant mortality.
The Val122Ile variant, highly prevalent in Black patients, portends poorer survival
compared with other ATTR-CM subtypes. Although Val122Ile is ...